Health Resources and Services Administration
Coverage of Health Resources and Services Administration in the Nexus archive.
- STAT+: Sales from controversial U.S. drug discount program rose to $100 billion last year
Sales under the U.S. 340B Drug Discount Program reached $100 billion in 2025, a 22.8% increase from the previous year. Expensive medicines accounted for 62% of spending, with Merck’s Keytruda and Gilead Sciences’ Biktarvy being the top two drugs by spending. The program requires drugmakers to offer 25-50% discounts to hospitals and clinics serving lower-income patients.
- New federal probe examines whether taxpayer dollars fund child gender transitions, legal defenses
Senator Bill Cassidy is investigating whether taxpayer dollars are funding child gender transitions and legal defenses for healthcare providers. The probe examines two Rhode Island health care providers and federal funding for community health centers. Cassidy demands answers on reports of providing puberty blockers and cross-sex hormones to minors.
- New federal probe examines whether taxpayer dollars fund child gender transitions, legal defenses
Senator Bill Cassidy is investigating whether taxpayer dollars are funding child gender transitions and legal defenses for healthcare providers. The probe examines federally supported health providers in Rhode Island, including Thundermist Health Center and Hasbro Children’s Hospital. The senator is seeking answers on the use of federal funds for gender transition-related services to minors.